Topical 15% resorcinol for hidradenitis suppurativa: An uncontrolled prospective trial with clinical and ultrasonographic follow-up - 23/11/17
Doi : 10.1016/j.jaad.2017.07.008
José C. Pascual, MD a, ⁎ 
, Belén Encabo, MD a, Rosa F. Ruiz de Apodaca, MD b, David Romero, MD a, Juan Selva, MD b, Gregor B. Jemec, MD c
, Belén Encabo, MD a, Rosa F. Ruiz de Apodaca, MD b, David Romero, MD a, Juan Selva, MD b, Gregor B. Jemec, MD c a Department of Dermatology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
b Department of Pharmacy, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
c Department of Dermatology, Zealand University Hospital Roskilde, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark
∗Reprint requests: José C. Pascual, MD, Servicio de Dermatología. Hospital General Universitario de Alicante, C/ Maestro Alonso s/n. CP:03010. Alicante, SpainServicio de Dermatología. Hospital General Universitario de AlicanteC/ Maestro Alonso s/n. CP:03010. AlicanteSpain
| Drs Pascual and Encabo share senior authorship. |
|
| Funding sources: None. |
|
| Disclosure: Dr Pascual has been an advisory board member for Abbvie. Dr Jemec has been an investigator, consultant, and advisory board member for Abbvie and Novartis and has received unrestricted grants from Abbvie, Leo Pharma, and Novartis. In addition, Dr Jemec has been a speaker and investigator for Leo Pharma; a speaker for Galderma; an investigator for Regeneron; and an advisory board member for Janssen-Cilag, Inflarx, MSD, and Pierre-FAbre. Drs Encabo, Ruiz de Apodaca, Romero, and Selva have no conflicts of interest to declare. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 77 - N° 6
P. 1175-1178 - décembre 2017 Retour au numéro
Article précédent
- Association between pemphigus and psoriasis: A population-based large-scale study
- Khalaf Kridin, Shira Zelber-Sagi, Doron Comaneshter, Arnon D. Cohen
- Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data
- Alice B. Gottlieb, Joseph F. Merola, Rongdean Chen, Eugenia Levi, Kristina Callis Duffin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?